XML 21 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]      
Revenues (Note 2) $ 4,434,000,000 $ 1,658,000,000 $ 55,000,000
Cost of revenues (Note 2) 6,464,000,000 4,781,000,000 520,000,000
Gross profit (2,030,000,000) (3,123,000,000) (465,000,000)
Operating expenses      
Research and development (Note 2) 1,995,000,000 1,944,000,000 1,850,000,000
Selling, general, and administrative (Note 2) 1,714,000,000 1,789,000,000 1,242,000,000
Other expenses (Note 2) 0 0 663,000,000
Total operating expenses 3,709,000,000 3,733,000,000 3,755,000,000
Loss from operations (5,739,000,000) (6,856,000,000) (4,220,000,000)
Interest income 522,000,000 193,000,000 3,000,000
Interest expense (220,000,000) (103,000,000) (29,000,000)
Loss on convertible notes, net (Note 8) 0 0 (441,000,000)
Other (expense) income, net 6,000,000 18,000,000 (1,000,000)
Loss before income taxes (5,431,000,000) (6,748,000,000) (4,688,000,000)
Provision for income taxes (1,000,000) (4,000,000) 0
Net loss (5,432,000,000) (6,752,000,000) (4,688,000,000)
Net loss attributable to common stockholders, basic (in shares) (5,432,000,000) (6,752,000,000) (4,688,000,000)
Net loss attributable to common stockholders, diluted (in shares) $ (5,432,000,000) $ (6,752,000,000) $ (4,688,000,000)
Net loss per share attributable to common stockholders, basic (in USD per share) $ (5.74) $ (7.40) $ (22.98)
Net loss per share attributable to common stockholders, diluted (in USD per share) $ (5.74) $ (7.40) $ (22.98)
Weighted average common shares outstanding - basic (in shares) 947 913 204
Weighted average common shares outstanding - diluted (in shares) 947 913 204